Gene · 3977
Papers2,592
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
761 to 780 of 2,592
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Effects of gestational exposure to bisphenol A on the hepatic transcriptome and lipidome of rat dams: Intergenerational comparison of effects in the offspring. | Sci Total Environ | 2022 | 35192832 | PubTator, text mining | PubMed |
| FUS-DDIT3 Fusion Oncoprotein Expression Affects JAK-STAT Signaling in Myxoid Liposarcoma. | Front Oncol | 2022 | 35186752 | PubTator, text mining | PubMed |
| Schwann Cells in the Tumor Microenvironment: Need More Attention. | J Oncol | 2022 | 35186076 | PubTator, text mining | PubMed |
| Regulatory networks and 5' partner usage of miRNA host gene fusions in breast cancer. | Int J Cancer | 2022 | 35182081 | PubTator, text mining | PubMed |
| Opportunities and challenges of patient-derived models in cancer research: patient-derived xenografts, patient-derived organoid and patient-derived cells. | World J Surg Oncol | 2022 | 35177071 | PubTator, text mining | PubMed |
| Leukemia inhibitory factor receptor homodimerization mediated by acetylation of extracellular lysine promotes prostate cancer progression through the PDPK1/AKT/GCN5 axis. | Clin Transl Med | 2022 | 35172032 | PubTator, text mining | PubMed |
| The Role of Oncostatin M and Its Receptor Complexes in Cardiomyocyte Protection, Regeneration, and Failure. | Int J Mol Sci | 2022 | 35163735 | PubTator, text mining | PubMed |
| IL-6 Cytokine Family: A Putative Target for Breast Cancer Prevention and Treatment. | Int J Mol Sci | 2022 | 35163731 | PubTator, text mining | PubMed |
| Pleiotropic, Unique and Shared Responses Elicited by IL-6 Family Cytokines in Human Vascular Endothelial Cells. | Int J Mol Sci | 2022 | 35163371 | PubTator, text mining | PubMed |
| Wnt and PI3K/Akt/mTOR Survival Pathways as Therapeutic Targets in Glioblastoma. | Int J Mol Sci | 2022 | 35163279 | PubTator, text mining | PubMed |
| Targeting the gp130/STAT3 Axis Attenuates Tumor Microenvironment Mediated Chemoresistance in Group 3 Medulloblastoma Cells. | Cells | 2022 | 35159191 | PubTator, text mining | PubMed |
| Cancer-Associated Fibroblasts and Tumor Cells in Pancreatic Cancer Microenvironment and Metastasis: Paracrine Regulators, Reciprocation and Exosomes. | Cancers (Basel) | 2022 | 35159011 | PubTator, text mining | PubMed |
| Metabolic Features of Tumor Dormancy: Possible Therapeutic Strategies. | Cancers (Basel) | 2022 | 35158815 | PubTator, text mining | PubMed |
| Recent Advances on Immunohistochemistry and Molecular Biology for the Diagnosis of Adnexal Sweat Gland Tumors. | Cancers (Basel) | 2022 | 35158743 | PubTator, text mining | PubMed |
| SYT-SSX1 enhances the invasiveness and maintains stem-like cell properties in synovial sarcoma via induction of TGF-β1/Smad signaling. | BMC Cancer | 2022 | 35151264 | PubTator, text mining | PubMed |
| Analysis of Genetic Variants and the ceRNA Network of miR-9 in Non-Small Cell Lung Cancer. | DNA Cell Biol | 2022 | 35143342 | PubTator, text mining | PubMed |
| Influence of BMI on adenosine deaminase and stroke outcomes in mechanical thrombectomy subjects. | Brain Behav Immun Health | 2022 | 35141572 | PubTator, text mining | PubMed |
| Rs12976445 polymorphism is associated with the risk of post-SAH re-bleeding by modulating the expression of microRNA-125 and ET-1. | Sci Rep | 2022 | 35136075 | PubTator, text mining | PubMed |
| Aggressive variants of prostate cancer: underlying mechanisms of neuroendocrine transdifferentiation. | J Exp Clin Cancer Res | 2022 | 35109899 | PubTator, text mining | PubMed |
| Leukaemia inhibitory factor in gastric cancer: friend or foe? | Gastric Cancer | 2022 | 35106710 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3977/papers?page=39